Thanks to an unexpected bequest of $8.5 million from fellow faculty member John Capaldi, Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, has funding to support more than 40 years’ worth of cancer research.
The Purdue Board of Trustees ratified a faculty naming and approved a new degree program, resolutions of appreciation, and work related to the new Mitchell E. Daniels, Jr. School of Business building.
Lilly Endowment Inc. has approved grants totaling $100 million to Purdue Research Foundation to support two major Purdue University initiatives, including $50 million each to support the Mitchell E. Daniels, Jr. School of Business and Purdue Computes. Together, these commitments represent the largest gift in the university’s history.
